Humana Inc.

HUM

US4448591028

Managed Healthcare

Delayed Nyse Other stock markets 04:00:02 2025-01-17 pm EST			5-day change	1st Jan Change
282.63 ^USD	+2.48%		+5.05%	+11.40%

Jan. 15	Piper Sandler Adjusts Price Target on Humana to $288 From $270, Maintains Neutral Rating	MT
Jan. 13	Equities Close Mixed as Traders Await Inflation Data, Bank Earnings	MT

Top Midday Decliners

July 31, 2024 at 02:57 pm EDT

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Humana Inc.

Piper Sandler Adjusts Price Target on Humana to $288 From $270, Maintains Neutral Rating	Jan. 15	MT
Equities Close Mixed as Traders Await Inflation Data, Bank Earnings	Jan. 13	MT
Equities Close Mixed as Traders Await Inflation Data, Bank Earnings	Jan. 13	MT
Equities Mixed Intraday as Markets Await Bank Earnings, Inflation Data	Jan. 13	MT
Humana Shares Rise After Wells Fargo Raises Price Target	Jan. 13	MT
Wells Fargo Adjusts Humana Price Target to $337 From $315, Maintains Overweight Rating	Jan. 13	MT
2025 will be the year of mergers and acquisitions: our predictions (part 2)	Jan. 08
Truist Securities Raises Price Target on Humana to $290 From $260, Hold Rating Maintained	Jan. 06	MT
Humana Insider Sold Shares Worth $948,925, According to a Recent SEC Filing	Jan. 03	MT
Equity Markets Rise as Traders Evaluate Macro Data	Dec. 20	MT
Equity Markets Rise as Traders Evaluate Macro Data	Dec. 20	MT
US Equities Markets End Higher Friday as Investors Evaluate Macro Data	Dec. 20	MT
Equities Rise Intraday as Traders Assess Macro Data	Dec. 20	MT
Humana Shares Climb; New Chief Information Officer Named	Dec. 20	MT
Humana Inc. Announces Board Changes	Dec. 20	CI
Baird Adjusts Humana Price Target to $270 From $374, Maintains Neutral Rating	Dec. 19	MT
Morgan Stanley Adjusts Price Target on Humana to $301 From $288	Dec. 17	MT
Nephron Research Downgrades Humana to Hold From Buy, $294 Price Target	Dec. 11	MT
Health insurer shares fall after UnitedHealth exec murder	Dec. 06	RE
Humana Names Celeste Mellet CFO	Dec. 03	MT
Humana says Susan Diamond to step down as CFO	Dec. 03	RE
Humana Appoints Celeste Mellet Finance Chief	Dec. 03	MT
Humana Inc. Announces CFO Changes	Dec. 03	CI
Wells Fargo Adjusts Price Target on Humana to $315 From $290, Maintains Overweight Rating	Nov. 18	MT
Tarsus Pharmaceuticals, Inc. Appoints Kate Goodrich, M.D., MHS, to Its Board of Directors	Nov. 13	CI

Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).

Employees

67,600

Sector

Managed Healthcare

Calendar

2025-02-11 - Q4 2024 Earnings Release

More about the company